Sector Watch

Sector Watch: Home health-care stocks

Lisa Springer | Jul 23, 2008 06:20am EDT | Comment
Rating: 4 out of 4 stars
Someone once said “There’s no place like home,” which doesn’t only ring true for wanderers far from Kansas. Many of today’s elderly, disabled or ailing may not choose to spend countless months in hospitals or clinics, and they now they have the option of in-home care by companies including Almost Family Inc. (Nasdaq:AFAM), Gentiva Health Services Inc. (Nasdaq:GTIV) and LHC Group, Inc. (Nasdaq:LHCG).

Home health-care providers will benefit from expanding Medicare enrollments, which are forecast to increase to 76.8 million by 2030 from 39.6 million in 2000. Rising home health-care spending, which is expected to grow nearly five-fold to $155 billion by 2017, reflects America’s patient preferences for care delivered at home, and the cost advantages of home health care. Costs for a day in a hospital or at a skilled nursing facility, for example, are estimated at $3,800 and $490, respectively, whereas a typical homecare visit costs around $100.

Almost Family, Inc. provides home health-care services in the Mid-West, East Coast and South. The company’s visiting nurse division supplies Medicare-certified home health nursing services to patients in need of recuperative care, while the personal care division provides in-home patient care on an as-needed, hourly or in-live basis. At year-end 2007, Almost Family operated 33 Medicare-certified home health agencies with 51 locations and 22 personal care locations.

The market reacted favorably to Almost Family’s June announcement that it was acquiring East Coast competitor Patient Care in a move that expanded the company’s presence in the Northeast with eight new locations; shares hit a 52-week high. The deal enables Almost Family to expand its footprint via new start-ups and will be . . .

For access to the full article, you must be a registered member - it's FREE.

Lisa Springer

About the Author
Contributing author Lisa Springer is an equity research analyst with nearly 20 years of investment research experience.